Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 111526255 | 11152625 | 5 | F | 201307 | 20160923 | 20150601 | 20160928 | EXP | US-ELI_LILLY_AND_COMPANY-US201505008090 | ELI LILLY AND CO | 55.12 | YR | M | Y | 113.38000 | KG | 20160928 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 111526255 | 11152625 | 1 | PS | AXIRON | TESTOSTERONE | 1 | Topical | UNK UNK, QD | N | U | 22504 | ORAL LIQUID | QD | ||||||
| 111526255 | 11152625 | 2 | SS | AXIRON | TESTOSTERONE | 1 | N | U | 22504 | ORAL LIQUID | |||||||||
| 111526255 | 11152625 | 3 | SS | AXIRON | TESTOSTERONE | 1 | N | U | 22504 | ORAL LIQUID | |||||||||
| 111526255 | 11152625 | 4 | SS | ANDROGEL | TESTOSTERONE | 1 | Unknown | UNK UNK, QD | D | U | 0 | INJECTION | QD | ||||||
| 111526255 | 11152625 | 5 | SS | ANDROGEL | TESTOSTERONE | 1 | D | U | 0 | INJECTION | |||||||||
| 111526255 | 11152625 | 6 | SS | ANDROGEL | TESTOSTERONE | 1 | D | U | 0 | INJECTION | |||||||||
| 111526255 | 11152625 | 7 | SS | TESTOSTERONE. | TESTOSTERONE | 1 | Unknown | UNK UNK, UNKNOWN | D | U | 0 | ||||||||
| 111526255 | 11152625 | 8 | SS | TESTOSTERONE. | TESTOSTERONE | 1 | D | U | 0 | ||||||||||
| 111526255 | 11152625 | 9 | SS | TESTOSTERONE. | TESTOSTERONE | 1 | D | U | 0 | ||||||||||
| 111526255 | 11152625 | 10 | C | ALOPURINOL | ALLOPURINOL | 1 | Unknown | UNK UNK, UNKNOWN | 0 | ||||||||||
| 111526255 | 11152625 | 11 | C | BABY ASPIRIN | ASPIRIN | 1 | Unknown | UNK UNK, UNKNOWN | 0 | ||||||||||
| 111526255 | 11152625 | 12 | C | COENZYME Q10 | UBIDECARENONE | 1 | Unknown | UNK | 0 | ||||||||||
| 111526255 | 11152625 | 13 | C | COENZYME Q10 | UBIDECARENONE | 1 | 0 | ||||||||||||
| 111526255 | 11152625 | 14 | C | MULTI VITAMIN | VITAMINS | 1 | Unknown | UNK UNK, UNKNOWN | 0 | ||||||||||
| 111526255 | 11152625 | 15 | C | OMEGA 3 /01333901/ | FISH OILTOCOPHEROL | 1 | Unknown | UNK UNK, UNKNOWN | 0 | ||||||||||
| 111526255 | 11152625 | 16 | C | TRENTAL | PENTOXIFYLLINE | 1 | Unknown | UNK UNK, UNKNOWN | 0 | ||||||||||
| 111526255 | 11152625 | 17 | C | ZOLOFT | SERTRALINE HYDROCHLORIDE | 1 | Unknown | UNK UNK, UNKNOWN | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 111526255 | 11152625 | 1 | Androgen deficiency |
| 111526255 | 11152625 | 2 | Blood testosterone decreased |
| 111526255 | 11152625 | 3 | Primary hypogonadism |
| 111526255 | 11152625 | 4 | Hormone replacement therapy |
| 111526255 | 11152625 | 5 | Blood testosterone decreased |
| 111526255 | 11152625 | 6 | Primary hypogonadism |
| 111526255 | 11152625 | 7 | Hormone replacement therapy |
| 111526255 | 11152625 | 8 | Blood testosterone decreased |
| 111526255 | 11152625 | 9 | Primary hypogonadism |
| 111526255 | 11152625 | 10 | Gout |
| 111526255 | 11152625 | 11 | Prophylaxis |
| 111526255 | 11152625 | 12 | Prophylaxis |
| 111526255 | 11152625 | 13 | Antioxidant therapy |
| 111526255 | 11152625 | 14 | Vitamin supplementation |
| 111526255 | 11152625 | 15 | Vitamin supplementation |
| 111526255 | 11152625 | 16 | Prophylaxis |
| 111526255 | 11152625 | 17 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 111526255 | 11152625 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 111526255 | 11152625 | Blindness | |
| 111526255 | 11152625 | Optic atrophy | |
| 111526255 | 11152625 | Optic ischaemic neuropathy | |
| 111526255 | 11152625 | Thrombosis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 111526255 | 11152625 | 1 | 2013 | 2013 | 0 | |
| 111526255 | 11152625 | 4 | 2010 | 2011 | 0 | |
| 111526255 | 11152625 | 7 | 2012 | 2013 | 0 | |
| 111526255 | 11152625 | 10 | 2012 | 0 | ||
| 111526255 | 11152625 | 11 | 2013 | 0 | ||
| 111526255 | 11152625 | 12 | 2005 | 0 | ||
| 111526255 | 11152625 | 15 | 2012 | 0 | ||
| 111526255 | 11152625 | 16 | 2013 | 0 | ||
| 111526255 | 11152625 | 17 | 2012 | 0 |